PUBLIC COMPANY
saveKyowa Kirin Co Ltd
updated 2mo ago
Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and was among the 40 largest in the world by revenue in 2012. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.
community read0 votes
🐶 often sniffed alongside
top 6pipeline
8
marketed
1
phase 3
1
catalysts ytd
3
approvals ytd
1
recalls ytd
0
Pipeline(8)
pipeline depth8 products
1Phase 13Phase 21Phase 31Marketed2Unknown
Marketed
mogamulizumab
Peripheral T-Cell Lymphomas (PTCL)
C-C chemokine receptor type 4
Phase 3azamidugene autotemcel
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Phase 2KK-8123
X-Linked Hypophosphatemic Rickets
Phase 2OTL-201
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Phase 2tivozanib
Wet (Neovascular / Exudative) Macular Degeneration
Platelet-derived growth factor receptor betaVascular endothelial growth factor receptor
Phase 1KK-2269
Solid Tumor
drugKK-4277
drugPOTELIGEO
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that